...
首页> 外文期刊>Medical Physics >Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography
【24h】

Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography

机译:氙增强计算机体层摄影术测量人肝中的血流和氙溶解度系数

获取原文
获取原文并翻译 | 示例

摘要

Purpose: The goal of this work was to develop a method of calculating blood flow and xenon solubility coefficient (λ) in the hepatic tissue by xenon-enhanced computed tomography (Xe-CT) and to demonstrate λ can be used as a measure of fat content in the human liver. Methods: A new blood supply model is introduced which incorporates both arterial blood and portal venous blood which join and together flow into hepatic tissue. We applied Ficks law to the model. It was theoretically derived that the time course of xenon concentration in the inflow blood (the mixture of the arterial blood and the portal venous blood) can be approximated by a monoexponential function. This approximation made it possible to obtain the time-course change rate (K I) of xenon concentration in the inflow blood using the time course of xenon concentration in the hepatic tissue by applying the algorithm we had reported previously. KI was used to calculate blood flow and λ for each pixel in the CT image of the liver. Twenty-six patients (49.2 ± 18.3 years) with nonalcoholic steatohepatitis underwent Xe-CT abdominal studies and liver biopsies. Steatosis of the liver was evaluated using the biopsy specimen and its severity was divided into ten grades according to the fat deposition percentage (severity 1) 10, 10 (severity 2) 20, , 90 (severity 10) 100. For each patient, blood flow and λ maps of the liver were created, and the average λ value (λ) was compared with steatosis severity and with the CT value ratio of the liver to the spleen (liverspleen ratio). Results: There were good correlations between λ and steatosis severity (r 0.914, P 0.0001), and between λ and liverspleen ratio (r -0.881, P 0.0001). Ostwald solubility for xenon in the hepatic tissue (tissue Xe solubility), which is calculated using λ and the hematocrit value of the patient, also showed a good correlation with steatosis severity (r 0.910, P 0.0001). λ ranged from 0.86 to 7.81, and tissue Xe solubility ranged from 0.12 to 1.16. This range of solubility is reasonable considering the reported Ostwald solubility coefficients for xenon in the normal liver and in the fat tissue are 0.10 and 1.3, respectively, at 37 °C. The average blood flow value ranged from 15.3 to 53.5 ml100 ml tissuemin. Conclusions: A method of calculating blood flow and λ in the hepatic tissue was developed by means of Xe-CT. This method would be valid even if portosystemic shunts exist; it is shown that λ maps can be used to deduce fat content in the liver. As a noninvasive modality, Xe-CT would be applicable to the quantitative study of fatty change in the human liver.
机译:目的:这项工作的目的是开发一种通过氙增强计算机体层摄影术(Xe-CT)计算肝脏组织中血流和氙溶解度系数(λ)的方法,并证明λ可以用作脂肪的量度人体肝脏中的含量。方法:引入一种新的供血模型,该模型结合了动脉血和门静脉血,两者汇合并一起流入肝组织。我们将菲克斯定律应用于该模型。从理论上可以得出,流入血液(动脉血和门静脉血的混合物)中氙浓度的时间过程可以通过单指数函数近似。这种近似使得通过应用我们先前报道的算法,可以利用肝组织中氙浓度的时程获得流入血液中氙浓度的时程变化率(K I)。 KI用于计算肝脏CT图像中每个像素的血流量和λ。 26例非酒精性脂肪性肝炎患者(49.2±18.3岁)接受了Xe-CT腹部检查和肝活检。使用活检标本评估肝脏的脂肪变性,并根据脂肪沉积百分比(严重程度1)10、10(严重程度2)20、90(严重程度10)100将严重程度分为十个等级。对于每个患者,血液创建肝脏的血流图和λ图,并将平均λ值(λ)与脂肪变性严重程度以及肝与脾的CT值比(肝脾比)进行比较。结果:λ与脂肪变性严重程度之间具有良好的相关性(r 0.914,P 0.0001),λ与肝脾比率之间具有良好的相关性(r -0.881,P 0.0001)。用λ和患者的血细胞比容值计算得出的氙在肝组织中的奥斯特瓦尔德溶解度(组织Xe溶解度)也显示出与脂肪变性严重程度的良好相关性(r 0.910,P 0.0001)。 λ在0.86至7.81的范围内,并且组织Xe溶解度在0.12至1.16的范围内。考虑到报道的氙在正常肝脏和脂肪组织中在37°C时的Ostwald溶解度系数分别为0.10和1.3,因此该溶解度范围是合理的。平均血流值范围为15.3至53.5 ml / 100 ml组织分钟。结论:利用Xe-CT开发了一种计算肝组织血流量和λ的方法。即使存在portosystemic分流器,该方法也将有效。结果表明,λ图可用于推导肝脏中的脂肪含量。作为一种非侵入性方式,Xe-CT将可用于人类肝脏脂肪变化的定量研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号